27 research outputs found
A prospective, single-blind, randomized controlled trial of petroleum jelly/Vaseline for recurrent paediatric epistaxis
No full textSuccinylation of Cottonseed Flour: Effect on the Functional Properties of Protein Isolates Prepared from Modified Flour
No full textReboisement de sites pollués – Enseignements tirés d'une étude de cas avec des métaux lourds | Reforestation of polluted soils – results of a case study on heavy metals
No full textPhysiological testing of coronary artery stenosis by computation of invasive coronary angiography. The wire-free functional imaging (WIFI-II) study
No full textCardiovascular Aspects of Radiolog
Low-Level Laser Therapy in Acute Pain: A Systematic Review of Possible Mechanisms of Action and Clinical Effects in Randomized Placebo-Controlled Trials
No full textEvaluation of Coronary Artery Stenosis by Quantitative Flow Ratio During Invasive Coronary Angiography The WIFI II Study (Wire-Free Functional Imaging II)
No full textCardiovascular Aspects of Radiolog
Prevention and Noninvasive Management of Coronary Atherosclerosis in Patients with Diabetes
No full textDiabetes mellitus (DM) is a worldwide epidemic. Its prevalence is rapidly increasing in both developing and developed countries. Coronary heart disease (CHD) is highly prevalent and is the major cause of morbidity and mortality in patients with diabetes. Individuals with prediabetes states, with or without known CHD, should undergo lifestyle modifications aimed at preventing DM. In patients with CHID and DM, routine use of aspirin and an angiotensin-converting enzyme inhibitor, along with strict glycemic, blood pressure, and lipid control, is strongly recommended. Intense insulin therapy may be needed for glycemic control, and high-dose statin therapy may be needed for lipid control. For blood pressure control, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are considered first-line therapy. Noncompliance with medications and/or lifestyle measures and, underprescription of evidence-based therapies remain important unsolved problems
